Literature DB >> 8303701

Tumor presence at resection boundaries and lymph-node metastasis in bronchial carcinoma patients.

K Kayser1, E Anyanwu, H G Bauer, I Vogt-Moykopf.   

Abstract

A prospective study was performed analyzing the bronchial resection boundaries of 120 patients operated on for lung carcinoma. The resection boundary, maximum tumor diameter, distance between tumor and resection boundary, and lymph-node stage were analyzed by serial sections of the surgical specimens (lobes and lungs). The following results were obtained: 20/120 cases (17%) displayed microscopic tumor invasion of the resection boundary (R1 status), most frequently adenocarcinoma (21%). The R1 status was closely associated with the distance between tumor and resection boundary and postsurgical lymph-node state (pN stage): all 8 tumors excised at distance 1 mm or less from the bronchial resection boundary revealed bronchial submucous tumor growth, whereas none of the tumors located more than 20 mm from the resection boundary was found to display tumor invasion of the bronchial boundary. Curative resection was noted in all 40 tumors operated at pNO stage and in only 11 cases (69%) of tumors with distant lymph-node metastases (pN3 stage). No relationship between tumor infiltration of the resection boundary and type of resection was seen. The data indicate that a) intra-operative control of bronchial resection boundaries is necessary in all lung-carcinoma patients with central tumor localization less than 20 mm from the proposed resection boundary; b) a "safety distance" between resection boundary and tumor boundary is of specific importance in bronchial carcinoma with lymph-node metastases.

Entities:  

Mesh:

Year:  1993        PMID: 8303701     DOI: 10.1055/s-2007-1013878

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  6 in total

1.  Swept source optical coherence microscopy using a 1310 nm VCSEL light source.

Authors:  Osman O Ahsen; Yuankai K Tao; Benjamin M Potsaid; Yuri Sheikine; James Jiang; Ireneusz Grulkowski; Tsung-Han Tsai; Vijaysekhar Jayaraman; Martin F Kraus; James L Connolly; Joachim Hornegger; Alex Cable; James G Fujimoto
Journal:  Opt Express       Date:  2013-07-29       Impact factor: 3.894

2.  Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States.

Authors:  Matthew P Smeltzer; Chun Chieh Lin; Feng-Ming Spring Kong; Ahmedin Jemal; Raymond U Osarogiagbon
Journal:  J Thorac Cardiovasc Surg       Date:  2017-04-04       Impact factor: 5.209

Review 3.  A narrative review of postoperative adjuvant radiotherapy for non-small cell lung cancer.

Authors:  Emanuela Olmetto; Marco Perna; Cecilia Cerbai; Michele Aquilano; Marco Banini; Matteo Mariotti; Lorenzo Livi; Vieri Scotti
Journal:  Mediastinum       Date:  2022-03-25

4.  Feasibility and safety of pedicled autologous bronchial flap reconstruction airway instead of sleeve lobectomy in partial lung cancer surgery.

Authors:  Zheng Zhang; Xiaonu Peng; Bo Ai; Kuo Li; Yang Li; Fernando C Abrão; Hitoshi Igai; Ricardo Mingarini Terra; Han Xiao; Quanfu Huang; Yongde Liao
Journal:  Transl Lung Cancer Res       Date:  2022-06

5.  Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.

Authors:  Raymond U Osarogiagbon; Chun Chieh Lin; Matthew P Smeltzer; Ahmedin Jemal
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

6.  Postoperative radiation therapy following the incomplete resection of a non-small cell lung cancer.

Authors:  Jaehyeon Park; Si Yeol Song; Su Ssan Kim; Sang-We Kim; Woo Sung Kim; Seung-Il Park; Dong Kwan Kim; Yong-Hee Kim; Jongmoo Park; Sang-Wook Lee; Jong Hoon Kim; Seung Do Ahn; Eun Kyung Choi
Journal:  Radiat Oncol J       Date:  2014-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.